Bank of New York Mellon’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding GLSI
GCP
SO
PFSRSONJ
FFA
Bank of New York Mellon's GLSI Position: Q2 2026 in Review
Bank of New York Mellon increased its Greenwich LifeSciences (GLSI) stake by 3% in Q2 2026, buying an estimated $33.5K and bringing the position to 47,900 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3291.
Bank of New York Mellon first reported a position in GLSI in Q2 2021 and has held it in 13 quarters since. 24 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.
- Bank of New York Mellon held 47,900 shares of Greenwich LifeSciences worth $1.12M as of Q2 2026.
- Bank of New York Mellon bought 1,377 Greenwich LifeSciences shares in Q2 2026, an estimated $33.5K.
- Greenwich LifeSciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3291 holding.
- Bank of New York Mellon first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 13 quarters since.
- 24 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.